This notion encouraged us to study the sortilin expression in bladder cancer cells and primary tumor tissues by IHC, ICC, and flow cytometry techniques to find a novel diagnostic method and a novel target to combat this malignancy. This evidence concerns the gene SORT1 and urinary bladder carcinoma.